FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3106304041> ?p ?o ?g. }

• W3106304041 endingPage "100124" @default.
• W3106304041 startingPage "100124" @default.
• W3106304041 abstract "Lung cancer is associated with severe coronavirus disease 2019 (COVID-19) infections. Symptom overlap between COVID-19 and lung cancer may complicate diagnostic evaluation. We aimed to investigate the incidence, symptoms, differential diagnosis, and outcomes of COVID-19 in patients with lung cancer.To determine an at-risk population for COVID-19, we retrospectively identified patients with lung cancer receiving longitudinal care within a single institution in the 12 months (April 1, 2019 to March 31, 2020) immediately preceding the COVID-19 pandemic, including an active therapy population treated within the last 60 days of this period. Among patients subsequently referred for COVID-19 testing, we compared symptoms, laboratory values, radiographic findings, and outcomes of positive versus negative patients.Between April 1, 2019 and March 31, 2020, a total of 696 patients received longitudinal care, including 406 (58%) in the active therapy population. Among 55 patients referred for COVID-19 testing, 24 (44%) were positive for COVID-19, representing a cumulative incidence of 3.4% (longitudinal population) and 1.5% (active therapy population). Compared with patients who were COVID-19 negative, those who were COVID-19 positive were more likely to have a supplemental oxygen requirement (11% versus 54%, p = 0.005) and to have typical COVID-19 pneumonia imaging findings (5 versus 56%, p = 0.001). Otherwise, there were no marked differences in presenting symptoms. Among patients who were COVID-19 negative, alternative etiologies included treatment-related toxicity (26%), atypical pneumonia (22%), and disease progression (22%). A total of 16 patients positive for COVID-19 (67%) required hospitalization, and seven (29%) died from COVID-related complications.COVID-19 was infrequent in this lung cancer population, but these patients experienced high rates of morbidity and mortality. Oncologists should maintain a low threshold for COVID-19 testing in patients with lung cancer presenting with acute symptoms." @default.
• W3106304041 created "2020-11-23" @default.
• W3106304041 creator A5005314279 @default.
• W3106304041 creator A5009318345 @default.
• W3106304041 creator A5009655890 @default.
• W3106304041 creator A5009871897 @default.
• W3106304041 creator A5016467233 @default.
• W3106304041 creator A5022162371 @default.
• W3106304041 creator A5025951912 @default.
• W3106304041 creator A5029774909 @default.
• W3106304041 creator A5032331306 @default.
• W3106304041 creator A5035343389 @default.
• W3106304041 creator A5037214933 @default.
• W3106304041 creator A5037376490 @default.
• W3106304041 creator A5052578824 @default.
• W3106304041 creator A5054608545 @default.
• W3106304041 creator A5064382279 @default.
• W3106304041 creator A5066069221 @default.
• W3106304041 creator A5067755945 @default.
• W3106304041 creator A5068125442 @default.
• W3106304041 creator A5069070706 @default.
• W3106304041 creator A5070741142 @default.
• W3106304041 creator A5077057876 @default.
• W3106304041 creator A5081227348 @default.
• W3106304041 creator A5083431383 @default.
• W3106304041 creator A5085217465 @default.
• W3106304041 creator A5087828708 @default.
• W3106304041 date "2021-01-01" @default.
• W3106304041 modified "2023-09-30" @default.
• W3106304041 title "Coronavirus Disease 2019 Infection in a Patient Population with Lung Cancer: Incidence, Presentation, and Alternative Diagnostic Considerations" @default.
• W3106304041 cites W2026274122 @default.
• W3106304041 cites W3001897055 @default.
• W3106304041 cites W3006355661 @default.
• W3106304041 cites W3012696018 @default.
• W3106304041 cites W3012860910 @default.
• W3106304041 cites W3013732976 @default.
• W3106304041 cites W3014153414 @default.
• W3106304041 cites W3015599879 @default.
• W3106304041 cites W3020041856 @default.
• W3106304041 cites W3023189656 @default.
• W3106304041 cites W3024048796 @default.
• W3106304041 cites W3030573714 @default.
• W3106304041 cites W3034965161 @default.
• W3106304041 cites W3035256826 @default.
• W3106304041 doi "https://doi.org/10.1016/j.jtocrr.2020.100124" @default.
• W3106304041 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7659804" @default.
• W3106304041 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33205053" @default.
• W3106304041 hasPublicationYear "2021" @default.
• W3106304041 type Work @default.
• W3106304041 sameAs 3106304041 @default.
• W3106304041 citedByCount "6" @default.
• W3106304041 countsByYear W31063040412021 @default.
• W3106304041 countsByYear W31063040412022 @default.
• W3106304041 countsByYear W31063040412023 @default.
• W3106304041 crossrefType "journal-article" @default.
• W3106304041 hasAuthorship W3106304041A5005314279 @default.
• W3106304041 hasAuthorship W3106304041A5009318345 @default.
• W3106304041 hasAuthorship W3106304041A5009655890 @default.
• W3106304041 hasAuthorship W3106304041A5009871897 @default.
• W3106304041 hasAuthorship W3106304041A5016467233 @default.
• W3106304041 hasAuthorship W3106304041A5022162371 @default.
• W3106304041 hasAuthorship W3106304041A5025951912 @default.
• W3106304041 hasAuthorship W3106304041A5029774909 @default.
• W3106304041 hasAuthorship W3106304041A5032331306 @default.
• W3106304041 hasAuthorship W3106304041A5035343389 @default.
• W3106304041 hasAuthorship W3106304041A5037214933 @default.
• W3106304041 hasAuthorship W3106304041A5037376490 @default.
• W3106304041 hasAuthorship W3106304041A5052578824 @default.
• W3106304041 hasAuthorship W3106304041A5054608545 @default.
• W3106304041 hasAuthorship W3106304041A5064382279 @default.
• W3106304041 hasAuthorship W3106304041A5066069221 @default.
• W3106304041 hasAuthorship W3106304041A5067755945 @default.
• W3106304041 hasAuthorship W3106304041A5068125442 @default.
• W3106304041 hasAuthorship W3106304041A5069070706 @default.
• W3106304041 hasAuthorship W3106304041A5070741142 @default.
• W3106304041 hasAuthorship W3106304041A5077057876 @default.
• W3106304041 hasAuthorship W3106304041A5081227348 @default.
• W3106304041 hasAuthorship W3106304041A5083431383 @default.
• W3106304041 hasAuthorship W3106304041A5085217465 @default.
• W3106304041 hasAuthorship W3106304041A5087828708 @default.
• W3106304041 hasBestOaLocation W31063040411 @default.
• W3106304041 hasConcept C120665830 @default.
• W3106304041 hasConcept C121332964 @default.
• W3106304041 hasConcept C121608353 @default.
• W3106304041 hasConcept C126322002 @default.
• W3106304041 hasConcept C187212893 @default.
• W3106304041 hasConcept C2776256026 @default.
• W3106304041 hasConcept C2777914695 @default.
• W3106304041 hasConcept C2908647359 @default.
• W3106304041 hasConcept C61511704 @default.
• W3106304041 hasConcept C71924100 @default.
• W3106304041 hasConcept C72563966 @default.
• W3106304041 hasConcept C88879693 @default.
• W3106304041 hasConcept C99454951 @default.
• W3106304041 hasConceptScore W3106304041C120665830 @default.
• W3106304041 hasConceptScore W3106304041C121332964 @default.
• W3106304041 hasConceptScore W3106304041C121608353 @default.
• W3106304041 hasConceptScore W3106304041C126322002 @default.

• next